Latest Regenerative February 27, 2025 News

Japan says iPSCs ready for mainstream adoption, in final approval stages to cover stem cell therapy for retinas under national health insurance

iPSC, Ophthalmology

February 27, 2025

MEDIPOST preparing for Phase 3 clinical trials of its umbilical cord stem cell product, Cartistem, appoints 5 new executives

Orthopedic, Perinatal

February 27, 2025